Literature DB >> 35237993

Redox Proteomics Analysis of Atherosclerotic Aortas: Application of the "OxICAT" Method.

Manousos Makridakis1, Antonia Vlahou2.   

Abstract

Atherosclerosis development and progression have been linked to vascular reactive oxygen species (ROS). Plaque formation and especially instability, frequently resulting in acute coronary syndromes, have been linked to cell apoptosis and senescence, but also mainly to increased cellular oxidative stress. ROS are characterized by their high chemical reactivity and a resulting short half-life. This high reactivity usually involves reversible and/or irreversible protein modifications and specifically the covalent oxidative modification of cysteine residues. The latter can be used for the identification of protein-chemical footprints, leading to indirect monitoring of ROS. Proteomics and especially liquid chromatography tandem mass spectrometry (LC-MS/MS) approaches have emerged as a powerful tool to identify such protein modifications in biological samples (e.g., body fluids, tissues, cells). Application of a well-established quantitative thiol trapping technique termed OxICAT enables the detection and quantification of oxidative thiol modifications of thousands of proteins in a single experiment. In this chapter, a step-by-step guide for the redox proteomics analysis of atherosclerotic aortas, by utilizing the OxICAT method, as optimized by our group is provided.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cysteine oxidation; OxICAT; Oxidative modifications; Reactive oxygen species; Redox proteomics

Mesh:

Substances:

Year:  2022        PMID: 35237993     DOI: 10.1007/978-1-0716-1924-7_39

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Mass spectrometry-based proteomics.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

Review 2.  Redox proteomics: from residue modifications to putative biomarker identification by gel- and LC-MS-based approaches.

Authors:  George Mermelekas; Manousos Makridakis; Thomas Koeck; Antonia Vlahou
Journal:  Expert Rev Proteomics       Date:  2013-12       Impact factor: 3.940

Review 3.  Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.

Authors:  Marika Mokou; Vasiliki Lygirou; Antonia Vlahou; Harald Mischak
Journal:  Expert Rev Proteomics       Date:  2017-01-05       Impact factor: 3.940

4.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.

Authors:  S P Gygi; B Rist; S A Gerber; F Turecek; M H Gelb; R Aebersold
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

5.  Type 1 IFN inhibits the growth factor deprived apoptosis of cultured human aortic endothelial cells and protects the cells from chemically induced oxidative cytotoxicity.

Authors:  Emiko Sano; Shinnya Tashiro; Hisashi Tadakuma; Toshiaki Takei; Takuya Ueda; Kouhei Tsumoto
Journal:  J Cell Biochem       Date:  2012-12       Impact factor: 4.429

6.  Quantifying changes in the thiol redox proteome upon oxidative stress in vivo.

Authors:  Lars I Leichert; Florian Gehrke; Harini V Gudiseva; Tom Blackwell; Marianne Ilbert; Angela K Walker; John R Strahler; Philip C Andrews; Ursula Jakob
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-14       Impact factor: 11.205

7.  Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice.

Authors:  Gillian Douglas; Jennifer K Bendall; Mark J Crabtree; Amy L Tatham; Emma E Carter; Ashley B Hale; Keith M Channon
Journal:  Cardiovasc Res       Date:  2012-01-27       Impact factor: 10.787

8.  Microarray gene expression profiling reveals antioxidant-like effects of angiotensin II inhibition in atherosclerosis.

Authors:  Joshua Abd Alla; Yasser El Faramawy; Ursula Quitterer
Journal:  Front Physiol       Date:  2013-06-19       Impact factor: 4.566

9.  Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.

Authors:  Johji Nomura; Nathalie Busso; Annette Ives; Chieko Matsui; Syunsuke Tsujimoto; Takashi Shirakura; Mizuho Tamura; Tsunefumi Kobayashi; Alexander So; Yoshihiro Yamanaka
Journal:  Sci Rep       Date:  2014-04-01       Impact factor: 4.379

10.  Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques.

Authors:  Shaoping Xu; Ali H Chamseddine; Samuel Carrell; Francis J Miller
Journal:  Redox Biol       Date:  2014-04-15       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.